Parse Biosciences, founded in 2018, is a biotechnology company that aims to provide researchers with single-cell solutions to streamline their experiments and discovery for objectives such as cancer treatment and stem cell therapy. Their Evercode products seek to use single-cell technology for gene capture at a greater scale and advanced data evaluation that strive to make it easier for researchers to quickly analyze results, all without having to use an instrument. Parse Biosciences is headquartered in Seattle, Washington.

Register for Details

For more details on financing and valuation for Parse Biosciences, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Parse Biosciences

Forge green plus iconForge green minus icon

Is Parse Biosciences a publicly traded company?

Parse Biosciences is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

Will Parse Biosciences go IPO?

Parse Biosciences has not yet filed for an IPO. However, it's important to note that IPOs are not the sole avenue for a private company to transition to public trading. Private companies can also go public through alternative methods such as but limited to Special Purpose Acquisition Companies (SPACs), direct listings, or through mergers and acquisitions. Find out which companies are eyeing an IPO on our Tech IPO Calendar 2024.

Forge green plus iconForge green minus icon

What is Parse Biosciences's IPO price?

The IPO price for Parse Biosciences will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Parse Biosciences pre-IPO?

Parse Biosciences is privately held company and is not publicly traded, therefor investing in Parse Biosciences pre-IPO is only available to accredited investors. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to invest in private companies before their potential IPO. If you are not an accredited investor, discover how to begin the the process to potentially qualify for new investment opportunities.

Forge green plus iconForge green minus icon

What is the value of my Parse Biosciences shares?

To determine the value of your Parse Biosciences shares, create a free account to gain access to Forge’s platform. Forge Markets contains pricing information for hundreds of pre-IPO companies. A Private Market Specialist will also be available to assist you with any inquiries related to your Parse Biosciences shares. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Can you sell Parse Biosciences before it goes public?

Yes, you can seek to sell shares in Parse Biosciences while it remains private. If you are considering selling, you can register today for free to get started. Once registered, a Private Market Specialist will guide you through any questions you might have. You may also continue to browse through our resources to help you understand the implications and procedures involved in selling your private market shares.

Forge green plus iconForge green minus icon

When was Parse Biosciences founded?

Parse Biosciences was founded in 2018.

Who are Parse Biosciences's major investors?

National Science Foundation
Janus Henderson Investors
Logos Capital
Soleus Capital
Sahsen Ventures
Saras Capital
Bioeconomy Capital
Vernon & Park Capital
Updated on: Jul 25, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.